# Protein Intake in Patients With Colorectal or Lung Cancer When Receiving a Nutritional Supplement

> **NCT05677958** · NA · COMPLETED · sponsor: **Nutricia Research** · enrollment: 126 (actual)

## Conditions studied

- Colorectal Cancer
- Lung Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** 125 mL Fortimel/Nutridrink Compact Protein

## Key facts

- **NCT ID:** NCT05677958
- **Lead sponsor:** Nutricia Research
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-17
- **Primary completion:** 2021-12-17
- **Final completion:** 2021-12-17
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05677958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05677958, "Protein Intake in Patients With Colorectal or Lung Cancer When Receiving a Nutritional Supplement". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05677958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*